The mission of Seqalis™ is to provide our customers with cutting-edge and high-quality laboratory testing and techniques but also with scientific advisory and research and development services, in Anatomical Pathology, Cytogenomics and Molecular Biology.
Seqalis™ collaborates intensively with its mother company, the Institute of Pathology and Genetics (IPG), one of the eight Belgian Genetics Centres, to continuously foster innovation in the medical and diagnostic fields.
Company Details
- Employees
- 11
- Founded
- -
- Address
- 25, Avenue Georges Lemaître, Gosselies,charleroi 6041,belgium
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Website
- bio-be.be
- Keywords
- CRO, NGS, Pathology, Oncology, Cell Therapy, Immuno-Oncology, TCR Sequencing, Cytogenomics, Micro-organisms.
- HQ
- Gosselies, Charleroi
Seqalis Questions
Seqalis's website is bio-be.be
Seqalis's LinkedIn profile is https://be.linkedin.com/company/seqalis
Seqalis has
11 employees.
View email and phone details for 11
employees at Seqalis.
Seqalis's industry is
Biotechnology Research
Seqalis's top competitors are
Iteos Therapeutics,
Syngulon,
Novadip Biosciences S.a.,
Institut De Pathologie Et De Génétique,
Amyl Therapeutics,
Cer Groupe,
Conveyxo,
Univercells,
Theratrame,
Celyad Oncology.
Seqalis's categories are Biotechnology Research
Seqalis's founding year is 2013
